The Patent Finder

Phosphoinositide 3-Kinase Inhibitor Compounds and Methods of Use

F. Hoffmann-La Roche AG

A patent family: one line of work, grouped by real continuity rather than by a technology label inferred from titles. 3 of these applications claim priority to application 60/873,448, filed Dec 7, 2006. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
PatentTitleHolderStatusExpiresTime remainingConfidence
US 8,383,620Phosphoinositide 3-Kinase Inhibitor Compounds and Methods of Use
In force
 · High confidence
F. Hoffmann-La Roche AGIn force
High confidence
US 8,993,563Phosphoinositide 3-Kinase Inhibitor Compounds and Methods of Use
In force
 · High confidence
Genentech, Inc. and F. Hoffmann-La Roche AGIn force
High confidence
US 7,888,352Phosphoinositide 3-Kinase Inhibitor Compounds and Methods of Use
In force
 · High confidence
F. Hoffmann-La Roche AGIn force
High confidence
3 of 3 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited